Navigation Links
Halo Therapeutics Reports Favorable Independent Review of Lead Drug Candidate HT-100
Date:3/20/2012

NEWTON, Mass., March 20, 2012 /PRNewswire/ -- Halo Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel therapeutics for rare fibrotic diseases, announced today that the TREAT-NMD Advisory Committee on Therapeutics (TACT) has reviewed HT-100, Halo's drug candidate for Duchenne muscular dystrophy (DMD), and believes the compound has potential based on the proposed mechanism. TREAT-NMD is a global network dedicated to expediting the delivery of promising new therapies to patients with neuromuscular disease. TACT provides independent, objective guidance on the therapeutic potential of drug candidates (novel or repurposed), which are submitted for review on a voluntary basis. In its review of HT-100, TACT found the drug candidate to be "ready for the clinic."

"TACT offers the opportunity for objective review of potential new therapies to help industry, researchers and patient advocacy groups. The review provides multi-disciplinary advice on the development of the potential therapies in the context of a realistic development pathway," said Volker Straub of TREAT-NMD. "TACT evaluated the proposal from Halo Therapeutics and felt it was well prepared, and that the compound has potential based on the proposed mechanism. Overall the plan to progress to a clinical trial is realistic."

DMD is a progressive and fatal neuromuscular disorder that afflicts approximately 1 in 3,500 boys worldwide.  HT-100, Halo's proprietary formulation of halofuginone, is an orally available small molecule drug candidate intended to reduce fibrosis and promote healthy muscle fiber regeneration. HT-100 works by inhibiting the pathological fibrotic process in muscle and directly stimulating healthy muscle fiber regeneration. The U.S. Food and Drug Administration recently granted orphan drug designation to HT-100. The company will begin a phase 2 study in the second half of 2012.

"We submitted HT-100 for a TACT review knowing that informed, objec
'/>"/>

SOURCE Halo Therapeutics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Echo Therapeutics, Inc. Announces 2011 Financial Results
2. Stemline Therapeutics Appoints Kevin Buchi, Former CEO of Cephalon, to Its Board of Directors
3. Nile Therapeutics Announces Upcoming Data Presentation at the American College of Cardiology Annual Scientific Meeting
4. Prime Therapeutics Announces CareCentered Contract™ with EMD Serono, Inc. for MS Drug Rebif®
5. ADHD Therapeutics Reviewed by NeuroPerspective
6. Cell Therapeutics, Inc. (CTI) Reports Fourth Quarter and Year-End Financial Results and Milestones
7. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2011 Financial Results on March 7
8. Particle Sciences Acquires Exclusive License to Lyotropic Therapeutics Drug Delivery Technology
9. Nektar Therapeutics Reports Fourth Quarter and Year-End 2011 Financial Results
10. Nektar Therapeutics Announces Agreement to Sell CIMZIA® and MIRCERA® Royalties to Royalty Pharma for $124 Million
11. Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... 1, 2014 Reportbuyer.com has added a ... Aesthetic Lasers and Energy Devices Market Outlook to ... Brazil Aesthetic Lasers and Energy Devices ... GlobalData,s new report, "Brazil Aesthetic Lasers ... key market data on the Brazil Aesthetic Lasers ...
(Date:9/1/2014)... Sept. 1, 2014 Reportbuyer.com has ... Rigid Transparent Plastics: Global Markets Outside ... INTRODUCTION This chapter provides ... the study goals and objectives, reasons for ... information sources and analyst credentials, and related ...
(Date:8/30/2014)... , Aug. 30, 2014   Royal Philips  (NYSE: ... Affiniti, a new ultrasound system designed to enable ... of increasing patient volumes and cost pressures. Making its ... in Barcelona this week, ... more patients with fewer resources deliver high quality patient ...
Breaking Medicine Technology:Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Rigid Transparent Plastics: Global Markets Outside North America 2Rigid Transparent Plastics: Global Markets Outside North America 3Rigid Transparent Plastics: Global Markets Outside North America 4Rigid Transparent Plastics: Global Markets Outside North America 5Rigid Transparent Plastics: Global Markets Outside North America 6Rigid Transparent Plastics: Global Markets Outside North America 7Rigid Transparent Plastics: Global Markets Outside North America 8Rigid Transparent Plastics: Global Markets Outside North America 9Rigid Transparent Plastics: Global Markets Outside North America 10Rigid Transparent Plastics: Global Markets Outside North America 11Rigid Transparent Plastics: Global Markets Outside North America 12Rigid Transparent Plastics: Global Markets Outside North America 13Rigid Transparent Plastics: Global Markets Outside North America 14Rigid Transparent Plastics: Global Markets Outside North America 15Rigid Transparent Plastics: Global Markets Outside North America 16Rigid Transparent Plastics: Global Markets Outside North America 17Rigid Transparent Plastics: Global Markets Outside North America 18Rigid Transparent Plastics: Global Markets Outside North America 19Rigid Transparent Plastics: Global Markets Outside North America 20Rigid Transparent Plastics: Global Markets Outside North America 21Rigid Transparent Plastics: Global Markets Outside North America 22Rigid Transparent Plastics: Global Markets Outside North America 23Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4
... CITY, Calif., Feb. 23, 2011 Abaxis, Inc. (Nasdaq: ... analysis systems, announced today that Clint Severson, chairman and chief ... Conference on Thursday, March 3, 2011 at 10:00 a.m. ET. ... Hotel in New York City. A live webcast ...
... Foundation and Vertex Pharmaceuticals announced today that VX-770, an oral ... cystic fibrosis, showed promising results in a Phase 3 clinical ... patients age 12 and up who carry at least one ... 161 patients who received at least one dose of VX-770 ...
Cached Medicine Technology:Abaxis, Inc. to Present at RBC Capital Markets' Healthcare Conference 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3
(Date:9/2/2014)... (PRWEB) September 02, 2014 Headaches, both chronic ... from going to work, enjoying family and friends, sleeping and ... is the single leading cause of disability worldwide. The ... carry serious risks. , Most of these cases of headache ... to treat them with prescriptions will not detect and fix ...
(Date:9/2/2014)... BESLER Consulting, a leading provider of Medicare ... to announce that it has released a special report ... 2015 Hospital Inpatient Prospective Payment System (IPPS) final rule ... Services. , “Hospitals are facing decreased Medicare reimbursements in ... BESLER’s President and Chief Executive Officer. “We are happy ...
(Date:9/2/2014)... 2014 With thoughts of getting the ... minds of many Washingtonians, it’s easy to forget that ... office managers to be booking their organizations’ holiday parties ... Washington, DC, area locations are preparing for the holiday ... for holiday parties, the space appears to be going ...
(Date:9/2/2014)... York (PRWEB) September 02, 2014 “Is ... is the question that millions of people ask. Diagnosing ... care providers, patients and their families or treatment partners. ... due to its distinct similarities to other skin conditions ... bed bug bites, eczema, varicella and many others. ...
(Date:9/2/2014)... OH (PRWEB) September 02, 2014 Request A ... testing, is offering a 10% discount on all drug testing ... savings, customers just need to use promo code DRUG10 when placing ... testing on urine, blood and hair. Drug testing is typically ... drugs. Some of the most popular panels include the ...
Breaking Medicine News(10 mins):Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 3Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 4Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 5Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 2Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 3Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 4Health News:Request A Test Offers 10% Off Drug Testing in September 2014 2Health News:Request A Test Offers 10% Off Drug Testing in September 2014 3
... Information Technology to Meet Today,s Healthcare Challenges, ... Quantum Group,Inc. (AMEX: QGP, QGP.WSA, QGP.WSB) ... CEO, Noel J. Guillama has been asked ... Corporation,s 7th Annual Life,Science Conference, "Leveraging Information ...
... Limited-edition CD at Participating Giant Stores on Saturday, May 3 and ... ... ,Everyone,s a winner when you stop into participating Giant stores,throughout the Washington ... Game(R) Scoop Day event., This year, EDY,S Grand Ice Cream hopes ...
... 22 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... presentations given at the Company,s Investor and,Analyst Day on ... Phase 1 and Phase 2 results of the Company,s ... design for AZ-004 (Staccato(R),loxapine), and discuss the role that ...
... Upholds Rights of 10,000 University of California RNs to ... Bargain Over Improved Patient ... victory for public,employees, the California Nurses Association/National Nurses Organizing,Committee today ... of California registered nurses it represents to strike, and to,bargain ...
... in light of a,recent study released by the ... is National STD Awareness Month, Congresswoman Stephanie Tubbs,Jones, ... a bi-partisan,resolution urging the House of Representatives to ... screening and treatment of,sexually transmitted diseases (STD)., ...
... warning to pregnant women that drug use can affect ... -- A combination of THC, the main psychoactive ingredient ... widespread nerve cell death in the brains of young ... Humboldt University, Berlin, administered THC, a synthetic form of ...
Cached Medicine News:Health News:The Quantum Group CEO to Deliver Keynote Address at EDC Life Science Conference 2Health News:The Quantum Group CEO to Deliver Keynote Address at EDC Life Science Conference 3Health News:EDY'S(R) SLOW CHURNED(R) and Giant Food Markets Announce Scoop Day With Sweet Deals to Support the Fight Against Childhood Cancer 2Health News:Alexza to Webcast Investor and Analyst Day Presentations 2Health News:Alexza to Webcast Investor and Analyst Day Presentations 3Health News:CNA/NNOC Wins Key Legal Decision Protecting Right of Public Employees to Strike 2Health News:Tubbs Jones Introduces Resolution Encouraging STD Prevention 2Health News:Pot Plus Alcohol Kills Young Rats' Brain Cells 2
Near point card/newspaper 8 to 48 point type 5 1/2" X 8"....
Rosenbaum card fits in the pocket (3.5 by 6.5") and shows point, Jaeger and distance equivalents from 20/800 to 20/20. Uses numbers, directional Es and XO patterns. For use at 14" (35 mm). Includes f...
Standard reading test. "Value, care for..."...
Standard reading test. "Clearing weather..."...
Medicine Products: